CoChat
Sign Up
Cited by 35

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

NO-dependent vasodilation and deep tumor penetration for cascade-amplified antitumor performance

Xu, Qing, Chen, Gui, Chen, Guimei, Wu, Hualan, Yang, Yuanyuan, Mai, Ziyi, Sun, Rui, Luan, Ping, Guo, Chaowan, Yu, Meng, Peng, Zhenwei, Yu, Zhiqiang·2022·Journal of Controlled Release
DOI 10.1016/j.jconrel.2022.05.022
Open this paper in CoChat — free account

Abstract

Nonspecific biodistribution and poor permeability of conventional therapeutic agents in solid tumors severely compromised the antitumor efficacy. Herein, we report a cascade tumor therapeutic nanoplatform consisting of docosahexaenoic acid (DHA) and nicorandil (NI), namely DNP, to specifically produce cytotoxic agents in tumor cells as well as dilating blood vessels to increase the intratumoral oxidative stress levels. The DHA embedded in the membrane could generate reactive oxygen species (ROS) meanwhile NI produced nitric oxide (NO) in response to intracellular glutathione (GSH) in tumors. Notably, the two functional species could further react in situ to form a more tumoricidal reactive nitrogen species (RNS), causing selectively cascade amplification of antitumor performance. In addition, NO-induced vasodilation could consequently result in a series of functions, including hypoxia relief and deep tumor transportation. In general, we anticipate that the DNP could show great potential for tumor-specific treatment by selectively producing RNS precursors in response to the interior environment of tumor cells for hypoxia normalization and tumor inhibition.

Overview

Integrity signals

Registry

Crossref · 10.1016/j.jconrel.2022.05.022

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 2 references

Research works printed but not linked: 47

  1. Cho, 2008, Therapeutic nanoparticles for drug delivery in cancer, Clin. Cancer Res., 14, 1310
  2. Liu, 2018, Integrative epigenetic analysis reveals therapeutic targets to the DNA methyltransferase inhibitor Guadecitabine (SGI-110) in hepatocellular carcinoma, Hepatology, 68, 1412
  3. Llovet, 2003, Hepatocellular carcinoma, Lancet, 362, 1907
  4. Finn, 2020, Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma, N. Engl. J. Med., 382, 1894
  5. Chang, 2020, Nanoparticle delivery of MnO2 and antiangiogenic therapy to overcome hypoxia-driven tumor escape and suppress hepatocellular carcinoma, ACS Appl. Mater. Interfaces, 12, 44407
  6. Zhou, 2020, A hepatocellular carcinoma targeting Nanostrategy with hypoxia-ameliorating and Photothermal abilities that, combined with immunotherapy, inhibits metastasis and recurrence, ACS Nano, 14, 12679
  7. Luo, 2016, Self-assembled redox dual-responsive prodrug-Nanosystem formed by single Thioether-bridged paclitaxel-fatty acid conjugate for Cancer chemotherapy, Nano Lett., 16, 5401
  8. Rahman, 2013, DHA is a more potent inhibitor of breast cancer metastasis to bone and related osteolysis than EPA, Breast Cancer Res. Treat., 141, 341
  9. Dierge, 2021, Peroxidation of n-3 and n-6 polyunsaturated fatty acids in the acidic tumor environment leads to ferroptosis-mediated anticancer effects, Cell Metab., 33, 1701
  10. Wen, 2016, Hepatic arterial infusion of low-density lipoprotein docosahexaenoic acid nanoparticles selectively disrupts redox balance in hepatoma cells and reduces growth of Orthotopic liver tumors in rats, Gastroenterology, 150, 488
  11. Hassannia, 2019, Vanden Berghe, targeting Ferroptosis to Iron out Cancer, Cancer Cell, 35, 830
  12. Ding, 2019, Engineered nanomedicines with enhanced tumor penetration, Nano Today, 29
  13. Wong, 2015, Dual-action combination therapy enhances angiogenesis while reducing tumor growth and spread, Cancer Cell, 27, 123
  14. Zhou, 2019, Light triggered oxygen-affording engines for repeated hypoxia-resistant photodynamic therapy, J. Control. Release, 307, 44
  15. Zhang, 2021, Photogenerated-hole-induced rapid elimination of solid tumors by the supramolecular porphyrin photocatalyst, Natl. Sci. Rev., 8
  16. Fan, 2019, Modulation of intracellular oxygen pressure by dual-drug nanoparticles to enhance photodynamic therapy, Adv. Funct. Mater., 29
  17. Zhao, 2020, Self-delivery nanomedicine for O2-economized photodynamic tumor therapy, Nano Lett., 20, 2062
  18. Zhao, 2021, Self-delivery oxidative stress amplifier for chemotherapy sensitized immunotherapy, Biomaterials, 275
  19. Szabo, 2016, Gasotransmitters in cancer: from pathophysiology to experimental therapy, Nat. Rev. Drug Discov., 15, 185
  20. Fukumura, 2006, The role of nitric oxide in tumour progression, Nat. Rev. Cancer, 6, 521
  21. Steinhorn, 2001, Recombinant human superoxide dismutase enhances the effect of inhaled nitric oxide in persistent pulmonary hypertension, Am. J. Respir. Crit. Care Med., 164, 834
  22. Chiarantini, 2003, Dinuclear copper(II) complex as nitric oxide scavenger in a stimulated murine macrophage model, Bioconjug. Chem., 14, 1165
  23. Dutra, 2013, Activity of nicorandil, a nicotinamide derivative with a nitrate group, in the experimental model of pain induced by formaldehyde in mice, Pharmacol. Biochem. Behav., 106, 85
  24. Sadamatsu, 2010, Acute effects of isosorbide dinitrate and nicorandil on the coronary slow flow phenomenon, Am. J. Cardiovasc. Drugs, 10, 203
  25. Ahmed, 2019, Nicorandil: a drug with ongoing benefits and different mechanisms in various diseased conditions, Indian J. Pharm., 51, 296
  26. Sun, 2020, Carry-on nitric-oxide luggage for enhanced chemotherapeutic efficacy, Nano Lett., 20, 5275
  27. Weidinger, 2015, Biological activities of reactive oxygen and nitrogen species: oxidative stress versus signal transduction, Biomolecules, 5, 472
  28. Deng, 2021, Tailoring supramolecular prodrug Nanoassemblies for reactive nitrogen species-potentiated chemotherapy of liver Cancer, ACS Nano, 15, 8663
  29. Du, 2018, X-Ray-controlled generation of peroxynitrite Based on nanosized LiLuF4 :Ce(3+) scintillators and their applications for radiosensitization, Adv. Mater., 30
  30. Feng, 2020, A biomimetic Nanogenerator of reactive nitrogen species based on battlefield transfer strategy for enhanced immunotherapy, Small, 16
  31. Deng, 2018, Nitric oxide as an all-rounder for enhanced photodynamic therapy: hypoxia relief, glutathione depletion and reactive nitrogen species generation, Biomaterials, 187, 55
  32. Hu, 2019, Nanoscale coordination polymers for synergistic NO and Chemodynamic therapy of liver Cancer, Nano Lett., 19, 2731
  33. Gao, 2019, Triggered ferroptotic polymer micelles for reversing multidrug resistance to chemotherapy, Biomaterials, 223
  34. Nogueira, 2013, Molecular pathways: reactive oxygen species homeostasis in cancer cells and implications for cancer therapy, Clin. Cancer Res., 19, 4309
  35. Rwei, 2015, Repeatable and adjustable on-demand sciatic nerve block with phototriggerable liposomes, Proc. Natl. Acad. Sci. U. S. A., 112, 15719
  36. Chmielarz, 1995, Studies on the double bond positional isomerization process in linseed oil by UV, IR and Raman spectroscopy, J. Mol. Struct., 348
  37. Chen, 2021, Recent advances of redox-responsive nanoplatforms for tumor theranostics, J. Control. Release, 332, 269
  38. Foret, 2020, Connecting the “dots”: from free radical lipid autoxidation to cell pathology and disease, Chem. Rev., 120, 12757
  39. Fan, 2017, Glucose-responsive sequential generation of hydrogen peroxide and nitric oxide for synergistic Cancer starving-like/gas therapy, Angew. Chem. Int. Ed. Eng., 56, 1229
  40. Wei, 2019, Near-infrared light switching nitric oxide nanoemitter for triple-combination therapy of multidrug resistant cancer, Acta Biomater., 100, 365
  41. Lala, 2001, Role of nitric oxide in carcinogenesis and tumour progression, Lancet Oncol., 2, 149
  42. Zou, 2020, Plasticity of ether lipids promotes ferroptosis susceptibility and evasion, Nature, 585, 603
  43. Ahsan, 2013, 3-Nitrotyrosine: a biomarker of nitrogen free radical species modified proteins in systemic autoimmunogenic conditions, Hum. Immunol., 74, 1392
  44. Yu, 2019, Multifunctional Nanoregulator reshapes immune microenvironment and enhances immune memory for tumor immunotherapy, Adv. Sci. (Weinh), 6, 1900037
  45. Sitkovsky, 2009, T regulatory cells: hypoxia-adenosinergic suppression and re-direction of the immune response, Trends Immunol., 30, 102
  46. Yang, 2020, Illuminating platinum transportation while maximizing therapeutic efficacy by gold nanoclusters via simultaneous near-infrared-I/II imaging and glutathione scavenging, ACS Nano, 14, 13536
  47. Zhang, 2020, Near-infrared light irradiation induced mild hyperthermia enhances glutathione depletion and DNA Interstrand cross-link formation for efficient chemotherapy, ACS Nano, 14, 14831

Cited by

Sorted by citations

See all 35

Metadata

Authors
Xu, Q., Chen, G., Chen, G., Wu, H., Yang, Y., Mai, Z., Sun, R., Luan, P., Guo, C., Yu, M., Peng, Z., & Yu, Z.
Venue
Journal of Controlled Release
Publisher
Elsevier BV
Published
2022-07
Volume
347
Pages
389-399
ISSN
0168-3659
DOI
10.1016/j.jconrel.2022.05.022
Cited by
35
References
2
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: NO-dependent vasodilation and deep tumor penetration for cascade-amplified antitumor performance. https://app.cochat.ai/papers/10.1016/j.jconrel.2022.05.022
The paper
Xu, Q., Chen, G., Chen, G., Wu, H., Yang, Y., Mai, Z., Sun, R., Luan, P., Guo, C., Yu, M., Peng, Z., & Yu, Z. (2022). NO-dependent vasodilation and deep tumor penetration for cascade-amplified antitumor performance. Journal of Controlled Release. https://doi.org/10.1016/j.jconrel.2022.05.022